Clinical Trial Update: Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 results update evaluating the efficacy and safety of oxycodone/naloxone controlled-release tablets versus placebo in opioid-experienced adults with chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Oxycodone/Naloxone controlled-release tablets (OXN) (oxycodone/naloxone)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2014-09-03